- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Pharmaceuticals - Community Register
Community register of medicinal products for human use |
AUTHORISED |
Product information |
| Invented name: | Torisel
|
| Auth. number : | EU/1/07/424 |
| Active substance : | Temsirolimus |
| Orphan market exclusivity for "Treatment of renal cell carcinoma" (based on designation EU/3/06/365) started on 21/11/2007 10 years of market exclusivity This orphan market exclusivity will expire on 21/11/2017 Orphan market exclusivity for "Treatment of mantle cell lymphoma" (based on designation EU/3/06/420) started on 25/08/2009 10 years of market exclusivity This orphan market exclusivity will expire on 25/08/2019 | |
| ATC: | Anatomical main group: L - Antineoplastic and immunomodulating agents Therapeutic subgroup: L01 - Antineoplastic agents Pharmacological subgroup: L01X - Other antineoplastic agents Chemical subgroup: L01XE - Protein kinase inhibitors Chemical substance: L01XE09 - Temsirolimus (See WHO ATC Index) |
| Indication: | Renal cell carcinoma: first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors Mantle cell lymphoma: treatment of adult patients with relapsed and/or refractory mantle cell lymphoma [MCL] |
| Marketing Authorisation Holder: | Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom |
|
EPAR and active package presentations | |
Package presentations | |
|
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register. |
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 21/11/2007 | Centralised - Authorisation | EMEA/H/C/799 | (2007)5681 of 19/11/2007 | |||
| 04/04/2008 | Centralised - Notification | EMEA/H/C/799/N/2 | ||||
| Updated with Decision(2009)4222 of 26/05/2009 | ||||||
| 19/11/2008 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/4 | ||||
| 17/12/2008 | Centralised - Variation | EMEA/H/C/799/IA/5 | ||||
| Updated with Decision(2009)4222 of 26/05/2009 | ||||||
| 09/01/2009 | Centralised - Variation | EMEA/H/C/799/II/3 | (2009)51 of 07/01/2009 | |||
| 24/04/2009 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/9 | ||||
| 24/04/2009 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/8 | ||||
| 28/05/2009 | Centralised - Variation | EMEA/H/C/799/II/6 | (2009)4222 of 26/05/2009 | |||
| 11/06/2009 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/7 | ||||
| 25/08/2009 | Centralised - Variation | EMEA/H/C/799/II/1 | (2009)6634 of 21/08/2009 | |||
| 10/09/2009 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/14 | ||||
| 25/09/2009 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/13 | ||||
| 25/09/2009 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/11 | ||||
| 25/09/2009 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/12 | ||||
| 16/10/2009 | Corrigendum | EMEA/H/C/799/II/1 | (2009)8006 cor of 14/10/2009 | |||
| 04/01/2010 | Centralised - Variation | EMEA/H/C/799/II/10 | (2009)10776 of 23/12/2009 | |||
| 27/01/2010 | Centralised - Variation | EMEA/H/C/799/II/15 | (2010)523 of 25/01/2010 | |||
| 23/04/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/23 | ||||
| 05/05/2010 | Centralised - Variation | EMEA/H/C/799/IA/17 | ||||
| Updated with Decision(2010)4706 of 02/07/2010 | ||||||
| 05/05/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/24 | ||||
| 05/05/2010 | Centralised - Variation | EMEA/H/C/799/IA/18 | ||||
| Updated with Decision(2010)4706 of 02/07/2010 | ||||||
| 05/05/2010 | Centralised - Variation | EMEA/H/C/799/IA/19 | ||||
| Updated with Decision(2010)4706 of 02/07/2010 | ||||||
| 05/05/2010 | Centralised - Variation | EMEA/H/C/799/IA/20 | ||||
| Updated with Decision(2010)4706 of 02/07/2010 | ||||||
| 05/05/2010 | Centralised - Variation | EMEA/H/C/799/IA/21 | ||||
| Updated with Decision(2010)4706 of 02/07/2010 | ||||||
| 02/07/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/22 | ||||
| 07/07/2010 | Centralised - Variation | EMEA/H/C/799/II/16 | (2010)4706 of 02/07/2010 | |||
| 12/07/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/26 | ||||
| 15/07/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/25 | ||||
| 14/10/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/30 | ||||
| 14/10/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IB/29 | ||||
| 14/10/2010 | Centralised - Variation (no change in Commission Decision) | EMEA/H/C/799/IA/28 | ||||
| 09/11/2010 | Centralised - Variation | EMEA/H/C/799/II/27 | (2010)7826 of 05/11/2010 | |||
| 15/12/2010 | Centralised - Variation | EMEA/H/C/799/IB/33 | ||||
| Updated with Decision(2011)469 of 24/01/2011 | ||||||
| 27/01/2011 | Centralised - Variation | EMEA/H/C/799/II/31 | (2011)469 of 24/01/2011 | |||
| 03/03/2011 | Centralised - Variation | EMEA/H/C/799/IB/34 | ||||
| Updated with Decision(2011)4624 of 23/06/2011 | ||||||
| 27/06/2011 | Centralised - Variation | EMEA/H/C/799/II/32 | (2011)4624 of 23/06/2011 | |||
| 06/09/2011 | Centralised - Transfer Marketing Authorisation Holder | EMEA/H/C/799/T/39 | (2011)6343 of 02/09/2011 | |||
| 09/12/2011 | Referral | EMEA/H/C/799/A-20/45 | (2011)9289 of 07/12/2011 | |||
| 30/05/2012 | Referral | EMEA/H/C/799/A-20/45 | (2012)3564 of 25/05/2012 | |||
| 24/09/2012 | Centralised - Renewal | EMEA/H/C/799/R/47 | (2012)6704 of 20/09/2012 | |||
| 26/09/2012 | Referral | EMEA/H/C/799/A-20/51 | (2012)6846 of 24/09/2012 | |||
| 15/11/2012 | Centralised - Variation | EMEA/H/C/799/II/52 | ||||
| Updated with Decision(2013)8345 of 20/11/2013 | ||||||
| 18/02/2013 | Centralised - Variation | EMEA/H/C/799/IAin/54 | ||||
| Updated with Decision(2013)8345 of 20/11/2013 | ||||||
| 27/06/2013 | Centralised - Variation | EMEA/H/C/799/II/55 | ||||
| Updated with Decision(2013)8345 of 20/11/2013 | ||||||
| 24/10/2013 | Centralised - Variation | EMEA/H/C/799/II/57 | ||||
| Updated with Decision(2013)8345 of 20/11/2013 | ||||||
| 22/11/2013 | Centralised - Yearly update | (2013)8345 of 20/11/2013 | ||||
| 25/10/2014 | Centralised - Variation | EMEA/H/C/799/II/58 | ||||
| Updated with Decision(2015)7206 of 15/10/2015 | ||||||
| 12/11/2014 | Centralised - Variation | EMEA/H/C/799/IB/59/G | ||||
| Updated with Decision(2015)7206 of 15/10/2015 | ||||||
| 24/06/2015 | Centralised - Notification | EMEA/H/C/799/N/60 | ||||
| Updated with Decision(2015)7206 of 15/10/2015 | ||||||
| 19/10/2015 | Centralised - Yearly update | (2015)7206 of 15/10/2015 | ||||
| 17/12/2015 | Centralised - Variation | EMEA/H/C/799/II/62 | ||||
| Updated with Decision(2016)8649 of 12/12/2016 | ||||||
| 18/01/2016 | PSUSA - Modification | EMEA/H/C/PSUSA/2887/201503 | (2016)228 of 14/01/2016 | |||
| 14/12/2016 | Centralised - Yearly update | (2016)8649 of 12/12/2016 | ||||
| 15/12/2016 | Centralised - Variation | EMEA/H/C/000799/II/0064 | ||||
| Updated with Decision(2017)5084 of 13/07/2017 | ||||||
| 23/02/2017 | Centralised - Variation | EMEA/H/C/000799/II/63 | ||||
| Updated with Decision(2017)5084 of 13/07/2017 | ||||||
| 17/07/2017 | Centralised - Renewal | EMEA/H/C/000799/R/0065 | (2017)5084 of 13/07/2017 |


